Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurgical Innovations Regulatory News (SUN)

Share Price Information for Surgical Innovations (SUN)

Share Price is delayed by 15 minutes
Get Live Data
0.50    0.00 (0.00%)
Bid:
0.45
Ask:
0.55
Spread: 0.10 (22.222%)
Market Cap: £4.66m
SUN Live PriceLast checked at - London Stock Exchange

Intraday Surgical Innovations Share Chart

Director/PDMR Shareholding

16 Oct 2018 10:53

RNS Number : 1971E
Surgical Innovations Group PLC
16 October 2018
Β 

Surgical Innovations Group plc

(the "Company")

Β 

Director/PDMR Shareholding

Β 

The Company has been notified that Nigel Rogers, Executive Chairman, today:

Β 

(i) acquired 750,000 ordinary shares of 1 penny each in the Company ("Shares") within his ISA, at a price of 2.95p per share;Β and

Β 

(ii) sold 416,830 Shares at a price of 2.95p perΒ share.

Β 

Following these transactions, the beneficial holding of Nigel Rogers in the Company is 6,610,000

Shares, representing approximately 0.84% of the issued share capital of the Company.

Β 

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Β 

For further information please contact:

Β 

Surgical Innovations Group plc

Nigel Rogers, Executive Chairman Melanie Ross, COO & CFO

Β 

WH Ireland Limited (NOMAD & Broker)

Tim Feather

Β 

Β 

Walbrook PR (Financial PR & Investor Relations)

Paul McManus Lianne Cawthorne

www.sigroupplc.com

Tel: 0113 230 7597

Β 

Tel: 0113 394 6600

Β 

Tel: 020 7933 8780 or si@walbrookpr.com

Mob: 07980 541893

Mob: 07584 391303

Β 

Β 

Β 

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Nigel Rogers

2

Reason for the notification

a)

Position/status

Executive Chairman, Surgical Innovations Group plc

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Surgical Innovations Group plc

b)

LEI

2138004GHGUH3HUZE156

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Β 

Identification code

Ordinary shares of 1p

Β 

Β 

Β 

GB0004016704

b)

Nature of the transactions

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

2.95p

750,000

d)

Aggregated information

- Aggregated volume

- Price

Β 

750,000

Β£22,125

e)

Date of the transaction

16 October 2018

f)

Place of the transaction

London Stock Exchange, AIM

Β 

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Nigel Rogers

2

Reason for the notification

a)

Position/status

Executive Chairman, Surgical Innovations Group plc

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Surgical Innovations Group plc

b)

LEI

2138004GHGUH3HUZE156

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Β 

Identification code

Ordinary shares of 1p

Β 

Β 

Β 

GB0004016704

b)

Nature of the transactions

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

2.95p

416,830

d)

Aggregated information

- Aggregated volume

- Price

Β 

416,830

Β£12,296

e)

Date of the transaction

16 October 2018

f)

Place of the transaction

London Stock Exchange, AIM

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHGCBDGCSBBGIL
Date   Source Headline
29th Sep 20087:00 amRNSInterim Results
16th Sep 20087:00 amRNSNotice of Results
11th Jul 20087:00 amRNSDirectorate Change
25th Jun 20082:15 pmRNSResult of AGM
25th Jun 200812:00 pmRNSAGM Statement
23rd Jun 20087:00 amPRNDirector/PDMR Shareholding
13th Jun 20081:18 pmRNSNotice of AGM
8th May 20081:00 pmRNSChange of Company Address
29th Apr 20087:01 amRNSFinal Results
7th Apr 20087:00 amRNSNotice of Results
9th Nov 20077:01 amRNSGrant of Options
2nd Oct 20077:01 amRNSDirectorate Appointment
27th Sep 20077:02 amRNSInterim Results
14th Sep 20077:00 amRNSNotice of Results
20th Aug 20077:02 amRNSAIM Rule 26 Information
30th Jul 20077:01 amRNSUS Distribution Agreement
29th Jun 200712:13 pmPRNHolding(s) in Company
29th Jun 200711:44 amPRNTotal Voting Rights
25th Jun 20072:15 pmRNSResult of AGM
25th Jun 200712:00 pmRNSAGM Statement
22nd Jun 200711:34 amPRNHolding(s) in Company
22nd Jun 200711:19 amPRNHolding(s) in Company
11th Jun 200711:24 amPRNResult of EGM
21st May 200712:05 pmPRNHolding(s) in Company
17th May 20077:00 amPRNPlacing
30th Apr 20077:02 amRNSFinal Results
12th Mar 20073:41 pmPRNHolding(s) in Company
5th Mar 20077:01 amRNSNotice of Results
8th Jan 20077:01 amRNSTrading Update
29th Dec 20069:51 amPRNTotal Voting Rights
18th Dec 20067:01 amRNSUS hospital group Agreement
7th Sep 20067:02 amRNSInterim Results
29th Aug 200611:27 amPRNIssue of Equity
8th Aug 20067:00 amRNSNotice of Results
27th Jun 20062:12 pmPRNAGM Statement
21st Mar 20067:00 amPRNNotice of Results
28th Sep 20056:00 amPRNInterim Results
19th Sep 20056:00 amPRNRe Agreement
16th Sep 200510:28 amPRNNotification of Results
1st Jul 20052:11 pmPRNConvertible Loan Notes
28th Jun 20053:00 pmPRNResult of AGM
8th Jun 20056:00 amPRNContract Extension
22nd Apr 20056:00 amPRNFinal Results
29th Mar 20053:10 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.